Guillaume R. Golovkine
195, Route D'Espagne
Toulouse, 31100, France
Toulouse, 31100, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
The role of cytochrome bc1 inhibitors in future tuberculosis treatment regimens.
Journal: Nature communications
Published: November 04, 2024
Author Correction: Autophagy restricts Mycobacterium tuberculosis during acute infection in mice.
Journal: Nature microbiology
Published: February 02, 2024
Deficiency in Galectin-3, -8, and -9 impairs immunity to chronic Mycobacterium tuberculosis infection but not acute infection with multiple intracellular pathogens.
Journal: PLoS pathogens
Published: December 28, 2022
Autophagy restricts Mycobacterium tuberculosis during acute infection in mice.
Journal: Nature microbiology
Published: September 03, 2021
Screening a Library of FDA-Approved and Bioactive Compounds for Antiviral Activity against SARS-CoV-2.
Journal: ACS infectious diseases
Published: June 15, 2021
Mapping of UV-C dose and SARS-CoV-2 viral inactivation across N95 respirators during decontamination.
Journal: Scientific reports
Published: June 11, 2021
Cas9+ conditionally-immortalized macrophages as a tool for bacterial pathogenesis and beyond.
Journal: eLife
Published: February 09, 2019
Evasion of autophagy mediated by Rickettsia surface protein OmpB is critical for virulence.
Journal: Nature microbiology
Published: September 06, 2018
Corrigendum: Pseudomonas aeruginosa Takes a Multi-Target Approach to Achieve Junction Breach.
Journal: Frontiers in cellular and infection microbiology
Published: January 24, 2018
Pseudomonas aeruginosa Takes a Multi-Target Approach to Achieve Junction Breach.
Journal: Frontiers in cellular and infection microbiology
Published: November 07, 2017
Last Updated: 09/26/2026